Ambiq (AMBQ) Q2 2026 earnings review
Hypergrowth is Here, But Supply Constraints Cap the Upside
Ambiq's strategic pivot to Edge AI is paying massive dividends. Q2 revenue accelerated to 90% YoY growth ($33.9M), marking the fifth consecutive quarter of sequential expansion. More importantly, gross margins expanded 450 basis points YoY to 47.2% as customers migrated to the higher-value Apollo 5 platform. However, the sheer velocity of demand is colliding with industry-wide supply limits, forcing Ambiq to leave revenue on the table. While the top-line story is pristine, the path to profitability remains distant: management is dramatically accelerating OpEx to pull forward its product roadmap, ensuring cash burn will continue despite the revenue boom.
🐂 Bull Case
Over 80% of units shipped are now running AI algorithms. Customers are aggressively upgrading to the Apollo 5 platform, which drives both unit volume and higher Average Selling Prices (ASPs).
Top-three customer concentration dropped from 86% a year ago to 71% in Q1, and revenue from non-wearable markets (medical, industrial) is expected to double in 2026.
🐻 Bear Case
Demand is growing faster than Ambiq's capacity. The CEO admitted they cannot meet short-lead-time orders, meaning physical supply constraints are actively throttling revenue growth.
Despite 90% revenue growth, the company is still guiding for heavy losses (-$0.16 EPS midpoint in Q3) as they aggressively scale R&D to fund next-generation chips like Atomiq.
⚖️ Verdict: 🟢
Bullish. The supply constraints and pushed-out profitability are real concerns, but they are symptoms of overwhelming product-market fit. Sustaining nearly 100% YoY growth while expanding gross margins proves Ambiq's core technology advantage is highly monetizable.
Key Themes
Apollo 5 Platform Driving Structural Mix Shift
The transition to the Apollo 5 platform is the engine of Ambiq's current success. Because Apollo 5 enables more complex AI workloads, it commands a higher ASP. This dynamic is solely responsible for Non-GAAP gross margins expanding from 42.7% in 25Q2 to 47.2% in 26Q2, driving gross profit up 109%—outpacing total revenue growth. Management confirmed this mix shift is a durable, multi-quarter tailwind.
Industry Supply Constraints & Substrate Costs
A critical macro roadblock has emerged: semiconductor supply chain bottlenecks. The CEO explicitly stated that the rapid acceleration in AI demand has led to supply constraints, forcing Ambiq to turn away expedited orders. Furthermore, rising industry-wide input costs (specifically substrate costs) are neutralizing Ambiq's internal yield improvements, preventing gross margins from breaking out much beyond the current ~47% ceiling despite the massive scale-up in volume.
Profitability Sacrifice for R&D Acceleration
There is a glaring contradiction in the P&L: revenue nearly doubled YoY, yet the company is guiding for Non-GAAP OpEx to spike to $24.0-$25.0M in Q3 (an 86% YoY increase). Management is actively choosing to delay profitability to fund the parallel development of the Apollo 340 and Atomiq 110/120 platforms. While strategic, this elevated burn rate means the breakeven point remains structurally elevated near $47M in quarterly revenue.
Software Tools as a Growth Multiplier
Ambiq is evolving from a pure silicon provider to a full-stack platform. The recent launch of heliaCORE and compressionKIT allows customers to deploy smaller, more energy-efficient AI models directly onto Apollo hardware. The CFO noted this software creates a 'one plus one equals three' dynamic, locking customers into the ecosystem and making the transition to competing hardware significantly more difficult.
Customer Diversification Reaching Escape Velocity
Ambiq's historical Achilles heel—extreme reliance on a few wearable customers—is being aggressively resolved. A 'new scaled global customer' is expected to begin mass production in 2026, and non-wearable pipeline (medical ECG/glucose monitors, industrial sensors) now represents 25% of the funnel. This provides a much-needed layer of revenue durability against consumer wearable cycles.
Persistent Customer Concentration
Despite progress in diversification, the reality remains that a handful of companies control Ambiq's fate. As of Q1 2026, the top three customers still accounted for 71% of total sales. If any of these anchor clients delay a product cycle or lose market share, Ambiq's hyper-growth narrative would face an immediate reversal.
Other KPIs
A massive war chest following the June public offering, up from $140.3M at year-end. This liquidity entirely derisks the company's aggressive R&D roadmap and shields the balance sheet from the ongoing cash burn required to reach profitability.
Calculated as Operating Cash Flow (-$20.7M) minus CapEx and Intangible Purchases (-$5.9M). The cash burn is accelerating as working capital demands (inventory grew by $12.4M to feed demand) and R&D investments compound. The recent capital raise was essential.
Guidance
Accelerating. The midpoint of $36.5M implies ~101% YoY growth, an acceleration from Q2's 90%. This marks the sixth consecutive quarter of sequential growth, confirming that Q2 was a baseline step-up, not a temporary peak.
Stable. The margin trajectory is flattening sequentially compared to Q2 (47.2%). This explicitly validates management's warning that rising industry component costs are eating into the margin benefits gained from internal yield improvements and product mix.
Accelerating. The midpoint represents a massive ~86% YoY increase and a sharp $5M sequential jump from Q2. This reflects the lumpy, project-based nature of IP purchases and contract engineering required for next-gen tape-outs.
Reversing trajectory compared to Q2's outperformance. The midpoint (-$0.16) implies the net loss will widen sequentially from Q2's -$0.07, entirely driven by the deliberate spike in OpEx.
Key Questions
Supply Chain Mitigation
You noted that you 'cannot meet' some short lead-time demand. What specific capacity agreements have you struck for H2 2026, and what percentage of your total demand do you estimate you are currently leaving unfulfilled?
Pricing Power Dynamics
Given the severe supply constraints and your unique low-power advantage in Edge AI, why are gross margins expected to remain flat? Why is the company absorbing industry cost increases instead of aggressively exercising pricing power?
Software Monetization
With the launch of heliaCORE and compressionKIT, are there plans to monetize these software layers as recurring revenue, or will they remain free tools designed strictly to drive silicon adoption?